Analyze Diet
Biochemical pharmacology1983; 32(4); 699-706; doi: 10.1016/0006-2952(83)90495-1

Dansylarginine N-(3-ethyl-1.5-pentanediyl)amide. A potent and selective fluorescent inhibitor of butyrylcholinesterase.

Abstract: Interactions between dansylarginine N-(3-ethyl-1,5-pentanediyl)amide (DAPA) and the cholinesterases were examined by the techniques of enzyme kinetics and fluorescence spectroscopy. When tested with partially purified enzyme preparations, DAPA was a potent inhibitor of butyrylcholinesterase (IC50 = 2 x 10(-7) M) but not of acetylcholinesterase (IC50 = 4 x 10(-4) M). For a detailed study of the effects of DAPA on butyrylcholinesterase (BuChE), the enzyme was purified to homogeneity from horse serum, with the aid of affinity chromatography on N-methyl acridinium. The kinetics of the inhibition of purified BuChE by DAPA were complex, having both competitive and non-competitive features, and it was not possible to estimate Ki unambiguously. Spectroscopic measurements showed that the fluorescence of the dansyl moiety was strongly affected by the binding to BuChE. With excitation at 330 nm, total fluorescence emission from bound DAPA (at 450 nm and above) was 21-fold greater than from free DAPA. In a titration experiment, this enhancement of fluorescence intensity was used to calculate that each monomer of BuChE has two apparently independent DAPA-binding sites with a Kd of 4.5 x 10(-7) M. Further measurements showed that the fluorescence emission of bound DAPA was markedly blue-shifted (to 502 nm from 570 nm in free solution) and that the fluorescence lifetime of this form was greatly prolonged (to 24 nsec from 2.7 nsec). These observations indicate that the high affinity binding sites on BuChE lock DAPA in a highly non-polar environment.
Publication Date: 1983-02-15 PubMed ID: 6830632DOI: 10.1016/0006-2952(83)90495-1Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article focuses on examining the interactions between dansylarginine N-(3-ethyl-1,5-pentanediyl)amide (DAPA) and the cholinesterases using enzyme kinetics and fluorescence spectroscopy, concluding that DAPA is a potent inhibitor of butyrylcholinesterase (BuChE), but not of acetylcholinesterase.

Research Methodology

  • The researchers used enzyme kinetics and fluorescence spectroscopy to study the interactions between DAPA and the cholinesterases. These techniques allow the determination of enzymatic reactions and behavior under various conditions.
  • DAPA’s potency was tested on partially purified enzyme preparations which helped the researchers to observe its inhibitory effect on the two enzymes – butyrylcholinesterase and acetylcholinesterase.
  • For a more detailed study of DAPA’s effects on BuChE, the enzyme was isolated from horse serum using a method called affinity chromatography.

DAPA’s Inhibitory Effect On Cholinesterases

  • The research showed that DAPA is a potent inhibitor of butyrylcholinesterase, inhibiting the enzyme with a half-maximal inhibitory concentration (IC50) value of 2 x 10(-7) M.
  • On the other hand, DAPA did not show a strong inhibitory effect on acetylcholinesterase, with an IC50 value of 4 x 10(-4) M, suggesting its selective nature for butyrylcholinesterase.
  • The kinetics of DAPA’s inhibition on BuChE were found to be complex with both competitive and non-competitive aspects, making it difficult to estimate the inhibition constant (Ki) unambiguously.

Spectroscopic Measurements And Binding Sites

  • Using spectroscopic measurements, the researchers observed that the fluorescence of the dansyl moiety in DAPA was strongly affected when it was bound to BuChE.
  • The study found a major enhancement in DAPA’s fluorescence emission when it was bound to BuChE, indicating that each monomer of BuChE has two independent DAPA-binding sites.
  • The enhancement of fluorescence intensity was used to calculate a dissociation constant (Kd), helping in the quantification of the binding affinity between the enzyme and DAPA.
  • In addition to increased fluorescence, the bound DAPA also exhibited a marked blue-shift in the emission spectrum and a lengthened fluorescence lifetime, indicating modification of its electronic environment upon binding to BuChE.

Important Findings

  • The findings indicate that the high affinity binding sites on BuChE create a highly non-polar environment, allowing DAPA to bind strongly to BuChE.
  • The research opens up avenues for understanding the interaction between DAPA and BuChE, and may potentially inform the development of selective inhibitors for therapeutic purposes.

Cite This Article

APA
Brimijoin S, Mintz KP, Prendergast FG. (1983). Dansylarginine N-(3-ethyl-1.5-pentanediyl)amide. A potent and selective fluorescent inhibitor of butyrylcholinesterase. Biochem Pharmacol, 32(4), 699-706. https://doi.org/10.1016/0006-2952(83)90495-1

Publication

ISSN: 0006-2952
NlmUniqueID: 0101032
Country: England
Language: English
Volume: 32
Issue: 4
Pages: 699-706

Researcher Affiliations

Brimijoin, S
    Mintz, K P
      Prendergast, F G

        MeSH Terms

        • Animals
        • Arginine / analogs & derivatives
        • Arginine / pharmacology
        • Cholinesterase Inhibitors
        • Dansyl Compounds
        • Horses
        • Kinetics
        • Protein Binding
        • Spectrometry, Fluorescence
        • Substrate Specificity

        Grant Funding

        • NS 11855 / NINDS NIH HHS

        Citations

        This article has been cited 0 times.